Hydroxychloroquine ‘offers no benefit’ to hospital patients with Covid-19

&Tab;&Tab;<div class&equals;"wpcnt">&NewLine;&Tab;&Tab;&Tab;<div class&equals;"wpa">&NewLine;&Tab;&Tab;&Tab;&Tab;<span class&equals;"wpa-about">Advertisements<&sol;span>&NewLine;&Tab;&Tab;&Tab;&Tab;<div class&equals;"u top&lowbar;amp">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;<amp-ad width&equals;"300" height&equals;"265"&NewLine;&Tab;&Tab; type&equals;"pubmine"&NewLine;&Tab;&Tab; data-siteid&equals;"111265417"&NewLine;&Tab;&Tab; data-section&equals;"1">&NewLine;&Tab;&Tab;<&sol;amp-ad>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;<&sol;div><p>The drug hydroxychloroquine offers no benefit to patients hospitalised with Covid-19&comma; according to a new study in The Lancet&period;<&sol;p>&NewLine;<p>Experts found that hydroxychloroquine – and a related medicine chloroquine – was linked to an increased risk of death and heart arrhythmias among people severely ill in hospital with coronavirus&period;<&sol;p>&NewLine;<p>US President Donald Trump has been criticised after he said he had nothing to lose by taking hydroxychloroquine&comma; which is used to treat malaria and arthritis&comma; despite warnings it could be unsafe&period;<&sol;p>&NewLine;<p>The authors of the new study said neither drug should be used to treat Covid-19 outside of clinical trials and said randomised clinical trials were needed&period;<&sol;p>&NewLine;<p>Earlier this week it was announced that a trial to see whether the drugs could prevent Covid-19 had begun in Brighton and Oxford&period;<&sol;p>&NewLine;<p>Chloroquine&comma; hydroxychloroquine or a placebo will be given to more than 40&comma;000 healthcare workers from Europe&comma; Africa&comma; Asia and South America&period;<&sol;p>&NewLine;<p>The Lancet study analysed data from almost 15&comma;000 patients with Covid-19 receiving the drugs and 81&comma;000 people who did not&period;<&sol;p>&NewLine;<p>Treatment with the medications among patients with Covid-19&comma; either alone or in combination with antibiotics&comma; was linked to an increased risk of serious heart rhythm complications and death&period;<&sol;p>&NewLine;<p>But the authors stressed that anyone taking these drugs for other conditions should not stop taking them as the trial looked specifically at Covid-19&period;<&sol;p>&NewLine;<p>Professor Mandeep Mehra&comma; lead author of the study and executive director of the Brigham and Women’s Hospital Centre for Advanced Heart Disease in Boston in the US&comma; said&colon; <i>&OpenCurlyDoubleQuote;This is the first large scale study to find statistically robust evidence that treatment with chloroquine or hydroxychloroquine does not benefit patients with Covid-19&period;<&sol;i><&sol;p>&NewLine;<p><i>&OpenCurlyDoubleQuote;Instead&comma; our findings suggest it may be associated with an increased risk of serious heart problems and increased risk of death&period;<&sol;i><&sol;p>&NewLine;<p><i>&OpenCurlyDoubleQuote;Randomised clinical trials are essential to confirm any harms or benefits associated with these agents&period;<&sol;i><&sol;p>&NewLine;<p><i>&OpenCurlyDoubleQuote;In the meantime&comma; we suggest these drugs should not be used as treatments for Covid-19 outside of clinical trials&period;”<&sol;i><&sol;p>&NewLine;<p>The researchers estimated that the excess risk attributable to the use of the drugs rather than other factors such as underlying health issues ranged from 34&percnt; to 45&percnt;&period;<&sol;p>&NewLine;<p>Dr Stephen Griffin&comma; associate professor in the school of medicine at the University of Leeds&comma; called for more research but said&colon; &OpenCurlyDoubleQuote;<i>This is potentially a landmark study for Covid-19 therapy&period;<&sol;i><&sol;p>&NewLine;<p><i>&OpenCurlyDoubleQuote;The key finding of this study is that neither single&comma; nor combination therapy with either chloroquine or hydroxychloroquine appear to provide any patient benefit in large numbers of Covid-19 infected patients&period;<&sol;i><&sol;p>&NewLine;<p><i>&OpenCurlyDoubleQuote;Moreover&comma; and worryingly&comma; such therapy actually may be harmful as treatment was associated with cardiovascular problems relating to heart rhythm&period;”<&sol;i><&sol;p>&NewLine;<p>Stephen Evans&comma; professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine&comma; said more research was needed&comma; but added&colon; &OpenCurlyDoubleQuote;<i>A definitive answer still awaits the results of the randomised trials&comma; but it is clear that the drugs should not be given for treatment of Covid-19 other than in the context of a randomised trial&period;<&sol;i><&sol;p>&NewLine;<p><i>&OpenCurlyDoubleQuote;It might even be said that to go on giving them other than in a trial is unethical&comma; given this evidence that is not yet contradicted by other available evidence&period;”<&sol;i><&sol;p>&NewLine;&Tab;&Tab;&Tab;<div style&equals;"padding-bottom&colon;15px&semi;" class&equals;"wordads-tag" data-slot-type&equals;"belowpost">&NewLine;&Tab;&Tab;&Tab;&Tab;<div id&equals;"atatags-dynamic-belowpost-68cd36f66efbf">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<script type&equals;"text&sol;javascript">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback &equals; function &lpar;&rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; false &equals;&equals;&equals; &lpar; window&period;isWatlV1 &quest;&quest; false &rpar; &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&sol;&sol; Use Aditude scripts&period;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings &equals; window&period;tudeMappings &vert;&vert; &lbrack;&rsqb;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings&period;push&lpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;divId&colon; 'atatags-dynamic-belowpost-68cd36f66efbf'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;format&colon; 'belowpost'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; document&period;readyState &equals;&equals;&equals; 'loading' &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;document&period;addEventListener&lpar; 'DOMContentLoaded'&comma; window&period;getAdSnippetCallback &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; else &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback&lpar;&rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<&sol;script>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>


Discover more from London Glossy Post

Subscribe to get the latest posts sent to your email.

- Advertisement -
Exit mobile version